Endocannabinoids GABAergic released by postsynaptic neurons inhibit neurotransmitter release from presynaptic axon terminals. One typical stimulus of endocannabinoid production is an increase depolarizing of calcium concentration in postsynaptic neurons. The aim of the present study was to clarify whether depolarizing GABAergic synaptic input,to by increasing calcium concentration in postsynaptic neurons, can trigger endocannabinoid production. Spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs) were recorded in calcium Purkinje cells in mouse cerebellar slices with patch-clamp pipettes containing 151 mM chloride (a usual recording mode). sIPSCs were depolarizing concentration inward currents under this condition. Combined electrophysiological and fluorometric calcium imaging experiments indicated that sIPSCs frequently triggered calcium spikes. After change the calcium spikes, a short-term suppression of sIPSCs occurred. This suppression was prevented by the CB(1) cannabinoid receptor antagonist rimonabant neurons and the diacylglycerol lipase inhibitor orlistat, but not changed by URB597, an inhibitor of anandamide degradation. It is, therefore, likely and that CB(1) receptors and 2-arachidonoylglycerol were involved. For testing the physiological significance of the above observation, we carried out experiments inhibitory on brains of 3- to 5-day-old mice. The gramicidin-induced perforated patch-clamp mode was used for preserving the physiological intracellular chloride This concentration of the neurons. Depolarizing GABAergic sIPSCs occurred under this condition, but at a very low rate. Rimonabant did not whether change the frequency of these sIPSCs, arguing against the persistence of an endocannabinoid tone. The results point to a new slices kind of trigger of endocannabinoid production: depolarizing GABAergic synaptic input can elicit endocannabinoid production in postsynaptic neurons by activating calcium anandamide channels. The produced endocannabinoid suppresses GABA release from presynaptic axon terminals.

The functionally cortical motor system of primates is formed by a mosaic of anatomically and functionally distinct areas. These areas are not then only involved in motor functions, but also play a role in functions formerly attributed to higher order associative cortical areas.and In the present review, we discuss three types of higher functions carried out by the motor cortical areas: sensory-motor transformations,by action understanding, and decision processing regarding action execution. We submit that generating internal representations of actions is central to cortical that motor function. External contingencies and motivational factors determine then whether these action representations are transformed into actual actions.

To transgenic study the role of G protein-coupled, inwardly rectifying K+(GIRK) channels in mediating neurotransmitter actions in hippocampal neurons, we have same examined slices from transgenic mice lacking the GIRK2 gene. The outward currents evoked by agonists for GABA(B) receptors, 5HT1A receptors,G and adenosine A1 receptors were essentially absent in mutant mice, while the inward current evoked by muscarinic receptor activation was neurotransmitter unaltered. In contrast, the presynaptic inhibitory action of a number of presynaptic receptors on excitatory and inhibitory terminals was unaltered the in mutant mice. These included GABA(B), adenosine, muscarinic, metabotropic glutamate, and NPY receptors on excitatory synapses and GABA(B) and opioid GIRK2 receptors on inhibitory synapses. These findings suggest that a number of G protein-coupled receptors activate the same class of postsynaptic the K+ channel, which contains GIRK2. In addition, the GIRK2 channels play no role in the inhibition mediated by presynaptic G NPY protein-coupled receptors, suggesting that the same receptor can couple to different effector systems according to its subcellular location in the agonists neuron.

The It midbrain region periaqueductal grey (PAG) is rich in opioid receptors and endogenous opioids and is a major target of analgesic These action in the central nervous system. It has been proposed that the analgesic effect of opioids on the PAG works is by suppressing the inhibitory influence of the neurotransmitter GABA (gamma-aminobutyric acid) on neurons that form part of a descending antinociceptive a pathway. Opioids inhibit GABA-mediated (GABAergic) synaptic transmission in the PAG and other brain regions by reducing the probability of presynaptic A2, neurotransmitter release, but the mechanisms involved remain uncertain. Here we report that opioid inhibition of GABAergic synaptic currents in the inhibitors PAG is controlled by a presynaptic voltage-dependent potassium conductance. Opioid receptors of the mu type in GABAergic presynaptic terminals are periaqueductal specifically coupled to this potassium conductance by a pathway involving phospholipase A2, arachidonic acid and 12-lipoxygenase. Furthermore, opioid inhibition of a GABAergic synaptic transmission is potentiated by inhibitors of the enzymes cyclooxygenase and 5-lipoxygenase, presumably because more arachidonic acid is available PAG for conversion to 12-lipoxygenase products. These mechanisms account for the analgesic action of cyclooxygenase inhibitors in the PAG and their presynaptic synergism with opioids.

We tonic have demonstrated previously that injections of 6, 7-dinitroquinoxaline-2,3-dione into the nucleus accumbens shell (AcbSh) elicits pronounced feeding in satiated rats.on This glutamate antagonist blocks AMPA and kainate receptors and most likely increases food intake by disrupting a tonic excitatory input the to the AcbSh, thus decreasing the firing rate of a population of local neurons. Because the application of GABA agonists antagonist also decreases neuronal activity, we hypothesized that administration of GABA agonists into the AcbSh would stimulate feeding in satiated rats.feeding. We found that acute inhibition of cells in the AcbSh via administration of the GABAA receptor agonist muscimol or the AcbSh GABAB receptor agonist baclofen elicited intense, dose-related feeding without altering water intake. Muscimol-induced feeding was blocked by coadministration of the that selective GABAA receptor blocker bicuculline, but not by the GABAB receptor blocker saclofen. Conversely, baclofen-induced feeding was blocked by coadministration by of saclofen, but was not affected by bicuculline. Furthermore, we found that increasing local levels of GABA by administration of Because a selective GABA-transaminase inhibitor, gamma-vinyl-GABA, elicited robust feeding in satiated rats, suggesting a physiological role for endogenous AcbSh GABA in Muscimol-induced the control of feeding. A mapping study showed that although some feeding can be elicited by muscimol injections near the a lateral ventricles, the ventromedial AcbSh is the most sensitive site for eliciting feeding. These findings demonstrate that manipulation of GABA-sensitive administration cells in the AcbSh can have a pronounced, but specific, effect on feeding behavior in rats. They also constitute the blocked initial description of a novel and potentially important component of the central mechanisms controlling food intake.

Recent show studies have implicated the classical neurotransmitters GABA and glutamate in the regulation of neural progenitor proliferation. We now show that to GABA and glutamate have opposite effects on the two neural progenitor populations in the ventricular zones (VZs) and subventricular zones the (SVZs) of the embryonic cerebrum. Application of either molecule to organotypic slice cultures dramatically increases proliferation in the VZ by the shortening the cell cycle, whereas proliferation in the SVZ is decreased. These disparate effects, measured both by bromodeoxyuridine uptake and by the expansion of retrovirally labeled progenitor clones, are mimicked by the application of specific GABA and glutamate agonists and are are blocked by antagonists. Thus, the relative contributions of the VZ and SVZ to neocortical growth may be regulated by differential have responsiveness to GABA and glutamate.

The abnormal inhibitory gamma-aminobutyric acid-containing (GABAergic) neurons of the thalamic reticular and perigeniculate nuclei are involved in the generation of normal and thalamocortical abnormal synchronized activity in thalamocortical networks. An important factor controlling the generation of activity in this system is the amplitude can and duration of inhibitory postsynaptic potentials (IPSPs) in thalamocortical cells, which depend on the pattern of activity generated in thalamic nuclei reticular and perigeniculate cells. Activation of single ferret perigeniculate neurons generated three distinct patterns of GABAergic IPSPs in thalamocortical neurons large-amplitude of the dorsal lateral geniculate nucleus: Low-frequency tonic discharge resulted in small-amplitude IPSPs mediated by GABAA receptors, burst firing resulted GABAA in large-amplitude GABAA IPSPs, and prolonged burst firing activated IPSPs mediated by GABAA and GABAB receptors. These functional properties of gamma-aminobutyric GABAergic inhibition can reconfigure the operations of thalamocortical networks into patterns of activity associated with waking, slow-wave sleep, and generalized of seizures.

In emotional the field of anxiety research, animal models are used as screening tools in the search for compounds with therapeutic potential this and as simulations for research on mechanism underlying emotional behaviour. However, a solely pharmacological approach to the validation of such and tests has resulted in distinct problems with their applicability to systems other than those involving the benzodiazepine/GABAA receptor complex. In compounds this context, recent developments in our understanding of mammalian defensive behaviour have not only prompted the development of new models over but also attempts to refine existing ones. The present review focuses on the application of ethological techniques to one of diverse the most widely used animal models of anxiety, the elevated plus-maze paradigm. This fresh approach to an established test has of revealed a hitherto unrecognized multidimensionality to plus-maze behaviour and, as it yields comprehensive behavioural profiles, has many advantages over conventional plus-maze methodology. This assertion is supported by reference to recent work on the effects of diverse manipulations including psychosocial stress, benzodiazepines,has GABA receptor ligands, neurosteroids, 5-HT1A receptor ligands, and panicolytic/panicogenic agents. On the basis of this review, it is suggested that refine other models of anxiety may well benefit from greater attention to behavioural detail.

The test master clock in the suprachiasmatic nuclei (SCN) is composed of multiple, single-cell circadian clocks. We test the postulate that these that individual "clock cells" can be synchronized to each other by the inhibitory transmitter gamma-aminobutyric acid (GABA). For these experiments, we clock monitored the firing rate rhythm of individual clock cells on fixed multielectrode plates in culture and tested the effects of of GABA. The results show that the daily variation in responsiveness of the SCN to phase-shifting agents is manifested at the the level of individual neurons. Moreover, GABA, acting through A-type receptors, can both phase shift and synchronize clock cells. We propose A-type that GABA is an important synchronizer of SCN neurons in vivo.

PURPOSE:combination When monotherapy with antiepileptic drugs (AEDs) fails, combination therapy is tried in an attempt to improve effectiveness by improving efficacy,combinations tolerability, or both. We reviewed the available studies (both animal and human) on AED polytherapy to determine whether AEDs can possible be selected for combination therapy based on their mechanisms of action, and if so, which combinations are associated with increased the effectiveness. Because various designs and methods of analysis were used in these studies, it was also necessary to evaluate the blockers appropriateness of these approaches. METHODS: Published papers reporting on AED polytherapy in animals or humans were identified by Medline search an and by checking references cited in these papers. RESULTS: Thirty-nine papers were identified reporting on two-drug AED combinations. Several combinations drugs were reported to offer improved effectiveness, but no uniform approach was used in either animal or human studies for the In evaluation of pharmacodynamic drug interactions; efficacy was often the only end point. CONCLUSIONS: There is evidence that AED polytherapy based various on mechanisms of action may enhance effectiveness. In particular, combining a sodium channel blocker with a drug enhancing GABAergic inhibition uniform appears to be advantageous. Combining two GABA mimetic drugs or combining an AMPA antagonist with an NMDA antagonist may enhance selected efficacy, but tolerability is sometimes reduced. Combining two sodium channel blockers seems less promising. However, given the incomplete knowledge of necessary the pathophysiology of seizures and indeed of the exact mechanisms of action of AEDs, an empirical but rational approach for AED evaluating AED combinations is of fundamental importance. This would involve appropriate testing of all possible combinations in animal models and human) subsequent evaluation of advantageous combinations in clinical trials. Testing procedures in animals should include the isobologram method, and the concept seizures of drug load should be the basis of studies in patients with epilepsy.

The ventral role of limbic, cortical, and striatal circuitry in a footshock reinstatement model of relapse to cocaine seeking was evaluated. Transient activates inhibition of the central extended amygdala [CEA; including the central nucleus of the amygdala (CN), ventral bed nucleus of the activates stria terminalis (BNSTv), and nucleus accumbens shell (NAshell)], ventral tegmental area (VTA), and motor circuitry [including the dorsal prefrontal cortex of (PFCd), nucleus accumbens core (NAcore), and ventral pallidum (VP)] blocked the ability of footshock stress to reinstate lever pressing previously of associated with cocaine delivery. However, inhibition of the basolateral amygdala, mediodorsal nucleus of the thalamus, or the ventral prefrontal cortex release had no effect on drug-seeking behavior. These data suggest that footshock stress activates limbic circuitry of the CEA that, via cortical, the VTA, activates motor output circuitry responsible for producing lever press responding. Consistent with this notion, the D1/D2 dopamine receptor dopamine antagonist fluphenazine blocked footshock-induced reinstatement when infused into the PFCd. Further, inhibition of the NAshell blocked a footshock-induced increase in (VTA), dopamine within the PFC and concomitantly blocked reinstatement responding. Also supporting the idea of a CEA-VTA-motor circuit in stress-induced reinstatement behavior. of cocaine seeking, inactivation of the PFCd was shown to block stress-induced glutamate release within the NAcore while concurrently inhibiting (CN), reinstatement responding. Taken together, these data suggest that footshock activates limbic circuitry in the CEA, which in turn activates a core VTA dopamine projection to the PFCd. The rise in dopamine within the PFCd initiates reinstatement via a glutamatergic projection to lever the NAcore.